CGCP | EVTR | CGCP / EVTR | |
Gain YTD | 5.309 | 5.896 | 90% |
Net Assets | 5.53B | 2.73B | 203% |
Total Expense Ratio | 0.34 | 0.32 | 106% |
Turnover | 83.00 | 367.00 | 23% |
Yield | 5.10 | 4.65 | 110% |
Fund Existence | 4 years | 41 years | - |
CGCP | EVTR | |
---|---|---|
RSI ODDS (%) | 1 day ago56% | 1 day ago41% |
Stochastic ODDS (%) | 1 day ago45% | 1 day ago32% |
Momentum ODDS (%) | 1 day ago59% | 1 day ago71% |
MACD ODDS (%) | 1 day ago66% | 1 day ago83% |
TrendWeek ODDS (%) | 1 day ago63% | 1 day ago74% |
TrendMonth ODDS (%) | 1 day ago63% | 1 day ago74% |
Advances ODDS (%) | 1 day ago58% | 1 day ago72% |
Declines ODDS (%) | 12 days ago54% | 12 days ago37% |
BollingerBands ODDS (%) | 1 day ago59% | 1 day ago40% |
Aroon ODDS (%) | 1 day ago70% | 1 day ago62% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
SPGM | 72.65 | 0.33 | +0.46% |
SPDR® Portfolio MSCI Global Stk Mkt ETF | |||
SXQG | 33.31 | 0.04 | +0.12% |
ETC 6 Meridian Quality Growth ETF | |||
RXI | 199.07 | N/A | N/A |
iShares Global Consumer Discr ETF | |||
IBRN | 24.96 | N/A | N/A |
iShares Neuroscience and Healthcare ETF | |||
JLQD | 41.76 | N/A | N/A |
Janus Henderson Corporate Bond ETF |
A.I.dvisor tells us that CGCP and NFE have been poorly correlated (+5% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CGCP and NFE's prices will move in lockstep.
Ticker / NAME | Correlation To CGCP | 1D Price Change % | ||
---|---|---|---|---|
CGCP | 100% | +0.18% | ||
NFE - CGCP | 5% Poorly correlated | +1.15% |